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Objectives: Risk factors related to Gradual onset injuries (GOIs) in cyclists need to be identified to enable
effective injury prevention strategies. We aim to determine risk factors related to GOIs in cyclists
participating in mass community-based events.
Design: Cross-sectional study.
Setting: Cape Town Cycle Tour.
Participants: Race entrants (n ¼ 35,914)
Main outcome measures: Completion of pre-race medical questionnaires. 21,824 consenting cyclists
(60.8%) were studied. 617 cyclists reported GOIs. Selected risk factors associated with GOIs: de-
mographics, training/racing history, chronic disease history, and medication use, were explored using
multi-variate analyses.
Results: Prevalence ratio (PR) of GOIs was similar in males and females, but higher in older age categories
[>50 yrs vs. categories: 30yrs (PR ¼ 1.6); 31 to 40yrs (PR ¼ 1.5); 41 to <50yrs (PR ¼ 1.4)] (p < 0.0001).
Intrinsic risk factors associated with GOIs (adjusted for gender and age) were: 1) increased weekly
training/racing frequency (PR ¼ 1.1, p ¼ 0.0003), 2) chronic disease history [cardiovascular disease
symptoms (PR ¼ 2.3, p ¼ 0.0026), respiratory disease (PR ¼ 1.6, p < 0.0001), nervous system/psychiatric
disease (PR ¼ 1.5, p ¼ 0.0082)], and 3) history of analgesic/anti-inflammatory medication (AAIM) used
before/during racing (PR ¼ 5.1, p < 0.0001).
Conclusion: Increased training frequency, chronic disease and AAIM use are risk factors associated with
GOIs in cyclists. A novel finding is that in recreational cyclists, chronic disease history could be consid-
ered when managing GOIs and implementing prevention programs.
© 2020 Elsevier Ltd. All rights reserved.1. Introduction
Cycling is a popular form of transportation, recreation, fitness
and sporting activity amongst people of all ages (Dahlquist et al.,nd Lifestyle Institute (SEMLI),
outh Africa, Sports Campus,
chwellnus).2015; De Bernardo et al., 2012; Kotler et al., 2016). However,
there is also a risk of acute traumatic and gradual onset injuries
(GOIs) in both amateur and professional cyclists (Barrios et al.,
2015; Decalzi et al., 2013; Roi & Tinti, 2014).
GOIs are defined as injuries without a specific, identifiable acute
event responsible for their occurrence (Clarsen et al., 2013). We
showed that about 3% of recreational cyclists report GOIs that are
severe enough to interferewith cycling or require treatment or seek
medical advice from a health professional (du Toit et al., 2020).
These GOIs in cyclists affect mostly the knee, lower back and
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and competition (du Toit et al., 2020). Of concern is that almost 50%
of cyclists with GOIs report a symptom duration >12 months (du
Toit et al., 2020). The principles of preventing GOIs rely on identi-
fying the underlying intrinsic (related to the cyclist) and extrinsic
(related to the bicycle and environment) risk factors associated
with GOIs (Clarsen et al., 2010). Risk factors associated with GOIs in
cyclists need to be identified so that effective injury prevention
programs can be designed and implemented.
There are limited studies on the risk factors associatedwith GOIs
in cyclists, and most studies have only focussed on biomechanical
risk factors, utilising a case-control study design (Baskins et al.,
2016; Bini et al., 2014; Streisfeld et al., 2017). Intrinsic risk factors
that have been associated with GOIs in cyclists include older age,
female gender, training load, anatomical malalignment and muscle
inflexibility of the lower limb (Dahlquist et al., 2015; Dettori &
Norvell, 2006; Kotler et al., 2016). Extrinsic risk factors associated
with GOIs in cyclists include training errors, cycling surfaces,
incorrect bicycle fitting, and adult or peer pressure (Bini et al., 2014;
Dettori & Norvell, 2006; Kotler et al., 2016). However, in the ma-
jority of these studies, the identification of intrinsic and extrinsic
risk factors was limited to studies in professional cyclists, utilising
relatively small sample sizes, and limiting the analyses to a uni-
variate exploration for risk factors associated with GOIs.
In a few studies (Dahlquist et al., 2015; Dannenberg et al., 1996;
Van derWalt et al., 2014;Weiss,1985;Wilber et al., 1995) where the
relationship between multiple risk factors associated with GOIs in
cyclists is reported, comparisons are difficult because of method-
ological differences that include: differences in the definition of
gradual onset injury (Dahlquist et al., 2015; Dannenberg et al., 1996;
Van der Walt et al., 2014; Wilber et al., 1995), reporting the expo-
sure (Dannenberg et al., 1996; Weiss, 1985), small sample sizes not
allowing for multivariate analysis (Dahlquist et al., 2015; Weiss,
1985; Wilber et al., 1995), low-response rates with possible selec-
tion bias (Van der Walt et al., 2014; Wilber et al., 1995), and the use
of self-reported data with differences in timing and content of
questionnaire administration (Dahlquist et al., 2015; Dannenberg
et al., 1996; Van der Walt et al., 2014; Weiss, 1985; Wilber et al.,
1995). Multivariate analysis to identify intrinsic risk factors was
only performed in two studies (Dahlquist et al., 2015; Wilber et al.,
1995).
The aim of this study was to determine selected intrinsic risk
factors associated with GOIs in recreational cyclists participating in
a 109 km, single-day, mass community-based cycling event. The
objectives were to explore the following specific risk factors asso-
ciated with GOIs in a large sample of recreational cyclists using a
multi-variate analysis: cyclist demographics (age group and
gender), cycling training/racing history, a history of existing chronic
disease, and medication usage.
2. Methods
A cross-sectional study designwas used. Prior to the onset of the
study, the Research Ethics Committee of the Faculty of Health Sci-
ences approved the study (REC numbers 431/2015 and 213/2017).
This study is part of a series of ongoing SAFER (Strategies to reduce
Adverse medical events For the ExerciseR) studies, for which data
collection is ongoing (Schwellnus & Derman, 2014).
The Cape Town Cycle Tour (CTCT) is an annual single-day road
cycle race hosted in Cape Town, South Africa, usually 109 km long. A
total of 35,914 cyclists entered the 2016 CTCT, and 21,902 gave
written informed consent for their data to be used for research
purposes. Seventy-eight cyclists had missing or incomplete injury
data leaving a final study population of 21,824 (60.8% of all race
entrants).138The response rate was acceptable, but we conducted a post-hoc
analysis to determine if the participants in this study were indeed
representative of all the cycle race entrants.
(du Toit et al., 2020) All cycle race entrants from the 2016 CTCT
were required to complete an online medical screening question-
naire at the time of registration. The online medical screening tool
consisted of a series of questions that were based on the guidelines
for cardiovascular evaluation of middle-aged/senior individuals
engaged in leisure-time sport activities (Position stand from the
European Association of Cardiovascular Prevention and Rehabili-
tation) (Borjesson et al., 2011), and our previous studies in distance
runners (Rotunno et al., 2018; Schwabe et al., 2018; Schwellnus
et al., 2019). We adapted the online screening tool for runners to
include questions specifically related to common medical compli-
cations encountered during cycling. The final screening questions
included the following: cycling training/racing history and medical
history which included history of acute traumatic and GOIs (cur-
rent, or recent e last 12 months), chronic cardiovascular disease
(CVD), risk factors for CVD, symptoms of CVD, respiratory disease,
metabolic or hormonal disease, GIT disease, nervous system dis-
ease, renal or bladder disease, haematological or immune system
disease, cancer, allergies, general medication usage for chronic
disease, and medication usage before and during racing.
In keeping with a recent IOC consensus paper (Bahr, Clarsen,
Derman, & al, 2020), we recognise that cycling injuries result
from a transfer of kinetic energy (agent) that damages tissue and
that this transfer of energy may result from: 1) a near-
instantaneous exchange of large quantities of kinetic energy (e.g.
cycling accident), 2) from the gradual accumulation of low-energy
transfer over time (as in the development of patellofemoral pain),
or 3) from a combination of both mechanisms (repetitive training
regime resulting in discal lower back pain that then manifests itself
acutely following a minor cycling accident) (Bahr, Clarsen, Derman,
& al, 2020). However, in our medical screening tool, which was
designed prior to the recent IOC consensus statement (Bahr,
Clarsen, Derman, & al, 2020), cyclists were specifically asked the
following question related to injuries: “Do you or did you suffer from
any symptoms of a CHRONIC (no accident) cycling injury (muscles
tendons bones ligaments or joints) IN YOUR CYCLING CAREER?”. We
therefore included only injuries where there was no self -reported
history of a near-instantaneous exchange of large quantities of ki-
netic energy (e.g. cycling accident), and we report these as GOIs.
The severity of a GOI was defined as: “An injury that is/was severe
enough to interfere with cycling or require treatment e.g. use medi-
cation or require you to seek medical advice from a health profes-
sional”. In response to a “yes” answer to this question, cyclists were
grouped as having a gradual onset injury (GOI group¼ 617). Cyclists
who reported no history of a GOI acted as controls (n ¼ 21,207).
In this descriptive cross-sectional study, various categories of
selected intrinsic risk factors associated with a past history of GOIs
in cyclists were explored:
 Demographic variables: Age groups (30 years, 31 to40 years,
41 to 50 years, >50 years) and gender (male, female)
 Cycling training/racing history variables: years of recreational
cycling, years of participation in distance cycling events of >2 h,
average number of training sessions per week in the last 12
months, average weekly distance in the last 12 months, and
average racing speed category.
 History of chronic disease: a history of existing CVD, risk factors
for CVD, symptoms of CVD, respiratory disease, endocrine dis-
ease, GIT disease, nervous system or psychiatric disease, kidney
or bladder disease, haematological system disease or immune
system disease, cancer, and allergies.
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age, and use of analgesic anti-inflammatory medication (AAIM)
(week before racing, during racing).
Analyses were conducted using SAS statistical software (version
9.4, Cary NC). The binary-scaled dependent variable in the model
was the response to the question related to GOIs. Cyclists were
coded as having a gradual onset cycling injury if they reported (1) a
chronic injury in the past 12 months or (2) a current chronic injury
or (3) a past chronic injury. Cyclists could report more than one GOI,
e.g. reporting both a neck and a shoulder injury. To qualify for
coding of an injury entry for (1) how long ago the injury started, (2)
which side of the body the injury was, and (3) the anatomical area
was coded. For 78 records, therewere discrepancies in the coding of
the relevant injury variables and these records were deleted from
the data. Since some modelling situations arose with convergence
problems, PROC GENMOD with the Poisson distribution with a log
link option were used and p values for Type 3 GEE (generalized
estimating equations) analysis were reported. The repeated state-
ment was included to allow for the correlated data as more than
one injury could be reported by the same cyclist (exchangeable
correlation structure). Prevalence ratios (PR) were calculated as the
measure of association. The statistical significance level was 5%,
unless specified otherwise. Univariate unadjusted prevalences (%
and 95%CIs) and prevalence ratios were reported for age and
gender, cycling training/racing history, history of chronic disease,
history of medication usage. The demographic, chronic disease,
history of medication variables were entered into the model as
categorical variables. The training and racing speed variables were
entered into the model as numeric variables and the prevalence of
GOIs (% and 95%CIs) were reported at the 1st quartile, median and
3rd quartile for these variables. The multiple regression initially
included all the univariate significant risk factors and indicated the
intrinsic risk factors for GOIs in cyclists and the final model con-
tained only the significant risk factors. The multiple regression
model was extended by adding the variable ‘average racing speed’
and was based on 18,703 consenting cycle race entrants, i.e. this
question had 14%missing responses and it was therefore decided to
not include the variable in the first multiple model. In the final
model, all interactions with age group and genderwere explored. In
the multivariate model, the level of significance was established at
p < 0.01.3. Results
The demographics of all cyclists entering the 2016 CTCT,
compared with the consenting cycle race entrants, that were par-
ticipants in this study, is outlined in Table 1.
The frequency (%) and crude unadjusted prevalence ratio (PR;Table 1
Characteristics of all cycle race entrants and cycle race entrants consenting as study part





Age groups (years) 30 6453
31 to 40 7814
41 to 50 10,583
>50 11,064
Study participants were significantly more likely to be in the >50-year age group (p < 0
a % out of total.
139with 95%CI) of cyclists with a history of GOIs by age group, and
gender is depicted in Table 2.
Gender was not associated with a higher PR of GOIs in cyclists
(PR ¼ 1.2, p ¼ 0.0610), while older age (>50 years) was associated
with a higher PR of GOIs in cyclists compared with all other age
groups (p < 0.0001).
The frequency (%) and crude unadjusted prevalence ratio (PR;
with 95%CI) of cyclists with a history of GOIs by cycling training/
racing history is depicted in Table 3.
The crude unadjusted analysis results show that a number of
training variables are associated with an increased prevalence ratio
of GOIs in cyclists. The highest PR of GOIs in cyclists was associated
with increased years of participation in distance cycling events >2 h
(PR ¼ 1.13; p < 0.0001), increased average weekly training/racing
frequency in the last 12 months (times per week) (PR ¼ 1.12,
p < 0.0001), increased average weekly cycling distance in the last
12 months (PR ¼ 1.08; p < 0.0001), increased years of recreational
cycling (years) (PR ¼ 1.08; p < 0.0001), and increased average
racing speed category (PR ¼ 1.06, p < 0.0001).
The frequency (%) and crude unadjusted prevalence ratio (PR;
with 95%CI) of cyclists with a history of GOIs by history of main
categories of chronic disease is depicted in Table 4.
The main observation is that a history of chronic disease is
associated with a higher PR of GOIs in cyclists. Specifically, the
crude unadjusted analysis showed that the highest PR of GOIs in
cyclists is associated with a history of any symptoms of CVD
(PR¼ 4.0; p < 0.0001), followed by a history of any nervous system/
psychiatric disease (PR ¼ 2.8; p < 0.0001), and any GIT disease
(PR ¼ 2.3; p < 0.0001). In addition, history of any respiratory dis-
ease (PR¼ 2.2; p < 0.0001), any kidney or bladder disease (PR¼ 2.1;
p ¼ 0.0009), any endocrine disease (PR ¼ 1.8; p ¼ 0.0050), any
allergies (PR ¼ 1.7; p < 0.0001), any history of CVD (PR ¼ 1.7;
p ¼ 0.0130), and any risk factor for CVD (PR ¼ 1.5; p < 0.0001) were
also associated with a higher risk of GOIs in cyclists.
The frequency (%) and crude unadjusted prevalence ratio (PR;
with 95%CI) of cyclists with a history of GOIs by regular use of any
prescription medications, and AAIM medication usage during
training and racing is depicted in Table 4.
The use of both regular prescribed medication for chronic dis-
ease (PR ¼ 1.7, p ¼ 0.0001) and use of any AAIM use in the week
before or during racing (PR ¼ 6.3, p¼ 0.0001) were associated with
a higher PR of GOIs in cyclists.
The multiple regression included all the significant risk factors
from the univariate analysis to determine intrinsic risk factors
associated with GOIs in cyclists. The frequency (%) and adjusted
prevalence ratio (PR; with 95%CI) of cyclists with a history of GOIs
by main categories of training load, history of chronic disease or
medications use, and injuries is depicted in Table 5.
In the multiple regression model, the training-related factoricipants (consenting cycle race entrants) (du Toit, 2020 e in review).
s Cycle race entrants
consenting as study
participants (n ¼ 21,824)
p-value
%a n %a
78.8 17,282 79.2 0.0390
21.2 4542 20.8




.0001), and to be male compared with all cycle race entrants (p ¼ 0.0390).
Table 2
The frequency (n, % and 95%CI) and unadjusted prevalence ratio (PR) (with 95%CI) of cyclists with a history of gradual onset injuries (GOIs) by gender and age group (univariate
analysis).
Characteristics Consenting cycle race entrants (n ¼ 21,824) Cycle race entrants with
gradual onset injuries
(GOIs) (n ¼ 617)
PR (95% CI) p-value
N n % (95% CI)
Gender Males 17,282 469 2.7 (2.5e3.0) 0.0610
Females 4542 148 3.3 (2.8e3.8) 1.2 (1.0e1.4)
Age groups (years) 30 3333 74 2.2 (1.8e2.8) 1.6 (1.2e2.1)b <0.0001a
31 to 40 4447 106 2.4 (2.0e2.9) 1.5 (1.2e1.9)c
41 to 50 6382 164 2.6 (2.2e3.0) 1.4 (1.1e1.7)d
>50 7662 273 3.6 (3.2e4.0)
PR: Prevalence Ratio.
a Significantly different between age groups.
b >50 vs  30 years, p ¼ 0.0003.
c >50 vs 31 to 40 years, p ¼ 0.0004.
d >50 vs 41 to 50 years, p ¼ 0.0008.
Table 3
The frequency (n, % and 95%CI) and unadjusted prevalence ratio (PR; with 95%CI) of cyclists with a history of gradual onset injuries (GOIs) by cycling training/racing history
(n ¼ 21,727) (univariate analysis).
Cycling training/racing history (n ¼ 21,727) Points in the
continuous variablea
Predicted frequency of cyclists with gradual onset injuries (GOIs) at
specific points in the continuous variable
% (95% CI)
PR (95% CI) p-value
Years of recreational cycling (yrs) 4yrs 2.5 (2.2e2.8) <0.0001
10yrs 2.7 (2.5e3.0)
18yrs 3.1 (2.8e3.3) 1.08 (1.04
e1.12)c
Years of participation in distance cycling events >2 h
(yrs)
3yrs 2.4 (2.2e2.6) <0.0001
6yrs 2.6 (2.3e2.8)
15yrs 3.2 (2.9e3.5) 1.13 (1.08
e1.17)c
Average weekly training/racing frequency in the last
12 months (times per week)
2/week 2.6 (2.4e2.8) <0.0001
3/week 2.9 (2.7e3.1)
4/week 3.2 (2.9e3.5) 1.12 (1.07
e1.16)d
Average weekly cycling distance in the last 12
months (km/week)
40 km 2.5 (2.3e2.8) <0.0001
80 km 2.7 (2.5e3.0)
130 km 3.0 (2.8e3.2) 1.08 (1.05
e1.11)e
Average racing speed category (km/h) n ¼ 18,703b 21.1 km/h 2.5 (2.2e2.8) <0.0001
24.8 km/h 2.8 (2.5e3.0)
29.2 km/h 3.2 (2.9e3.5) 1.06 (1.03
e1.09)f
PR: Prevalence Ratio.
a Points on the continuous variables are the 1stquartile, median and 3rdquartile for each training variable.
b Variable has 14% missing responses.
c Average increase in risk for a 5-year increase.
d Average increase in risk for 1 more training session per week.
e Average increase in risk for 40 km more training per week.
f Average increase in risk for 2 km/h increase in speed.
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average weekly training/racing frequency in the last 12 months
(times per week) (PR ¼ 1.1, p ¼ 0.0003). Secondly, GOIs in cyclists
were associated with a history of chronic disease as follows: any
symptoms of CVD (PR ¼ 2.3, p ¼ 0.0026), any respiratory disease
(PR ¼ 1.6, p < 0.0001), and any nervous system/psychiatric disease
(PR ¼ 1.5, p ¼ 0.0082). Finally, a history of any AAIM used in the
week before or during racing was associated with a higher PR of
GOIs in cyclists (PR ¼ 5.1, p < 0.0001).
Further modelling showed that the interaction for age group
(50; >51 years) and respiratory disease was significant
(p ¼ 0.008). The results showed that the respiratory disease PR for
older athletes was 1.2 (95%CI: 0.9e1.6, respiratory disease
positive¼ 12.5% and negative¼ 10.6%) and for younger athletes the
PRwas 2.0 (95%CI: 1.5e2.5, respiratory disease positive¼ 15.4% and
negative ¼ 7.9%) indicating that respiratory disease was a predictor140of GOIs in cyclists for younger cyclists, but not for older athletes.
4. Discussion
The main finding of this study is that a history of certain chronic
diseases (any symptoms of CVD, any respiratory disease, and any
nervous system/psychiatric disease) are intrinsic risk factors asso-
ciated with GOIs in cyclists. An increased average weekly training/
racing frequencywas also associatedwith GOCIs.We also show that
a history of any AAIM use in the week before or during racing is
associated with GOCIs. The prevalence risk of GOIs in cyclists was
not significantly different between genders, but was higher in the
>50 years, compared to other age groups.
As far as we are aware, this is the first study to report an asso-
ciation between a variety of underlying chronic diseases and GOIs
in recreational cyclists. The prevalence of chronic disease in
Table 4
The frequency (n, % and 95%CI) and unadjusted prevalence ratio (PR) of cyclists with a history of gradual onset injuries (GOIs) by history of main category of chronic disease and
by history of regular use of any medications, and use of medication during training and racing (univariate analysis).




PR (95% CI) p-value
N n % (95% CI)
History of chronic disease
Any risk factor for CVD yes 4525 178 3.9 (3.4e4.5) 1.5 (1.3e1.8) <0.0001
no 17,089 439 2.6 (2.3e2.8)
missing data 210 0
Any history of CVD yes 817 38 4.7 (3.4e6.3) 1.7 (1.2e2.3) 0.0130
no 20,797 579 2.8 (2.6e3.0)
missing data 210 0
Any symptoms of CVD yes 233 26 11.2 (7.8e16.0) 4.0 (2.8e5.8) <0.0001
no 21,381 591 2.8 (2.6e3.0)
missing data 210 0
Any endocrine disease yes 835 41 4.9 (3.6e6.6) 1.8 (1.3e2.4) 0.0050
no 20,784 573 2.8 (2.5e3.0)
missing data 205 3
Any respiratory disease yes 2482 135 5.4 (4.6e6.4) 2.2 (1.8e2.6) <0.0001
no 19,157 482 2.5 (2.3e2.7)
missing data 185 0
Any GIT disease yes 1169 70 6.0 (4.8e7.5) 2.3 (1.8e2.9) <0.0001
no 20,456 543 2.7 (2.4e2.9)
missing data 199 4
Any nervous system/psychiatric disease yes 767 58 7.6 (5.9e9.7) 2.8 (2.2e3.7) <0.0001
no 20,864 557 2.7 (2.5e2.9)
missing data 193 2
Any kidney or bladder disease yes 645 38 5.9 (4.3e8.0) 2.1 (1.6e2.9) 0.0009
no 20,990 578 2.8 (2.5e3.0)
missing data 189 1
Any haematological or immune disease yes 293 15 5.1 (3.1e8.4) 1.8 (1.1e3.0) 0.0760
no 21,325 600 2.8 (2.6e3.0)
missing data 206 2
Any cancer yes 701 28 4.0 (2.8e5.7) 1.4 (1.0e2.1) 0.1130
no 20,926 587 2.8 (2.6e3.0)
missing data 197 2
Any allergies yes 2968 133 4.5 (3.8e5.3) 1.7 (1.4e2.1) <0.0001
no 18,659 482 2.6 (2.4e2.8)
missing data 197 2
History of medication usage
Any regular prescribed medication usage for chronic disease yes 5505 229 4.2 (3.7e4.7) 1.7 (1.5e2.0) 0.0001
no 16,126 388 2.4 (2.2e2.7)
missing data 193 0
Any AAIM use in the week before or during racing yes 1892 231 12.2 (10.8e13.8) 6.3 (5.4e7.3) 0.0001
no 19,658 383 1.9 (1.8e2.2)
missing data 274 3
CVD: Cardiovascular disease.
GIT: Gastrointestinal disease.
n: number of cyclists in the study.
PR: Prevalence ratio.
AAIM: analgesic/anti-inflammatory medication.
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Wilber et al., 1995), and this is likely to increase as the age of par-
ticipants in recreational cycling increases. The potential mecha-
nism/s to explain the relationship between chronic disease and risk
of GOIs in recreational cyclists requires further study, but there is
some evidence that chronic diseases may be related to increased
risk of GOIs (Abate et al., 2013; Abboud & Kim, 2010; Applegate
et al., 2017; Daga et al., 2018; Graat-Verboom et al., 2009; Lin
et al., 2015; Mammen, 2016; Marie et al., 2008). More specifically,
chronic disease in a number of organ systems or medication that is
used to treat chronic disease, are related to tendinopathies (Abate
et al., 2013; Applegate et al., 2017; Lin et al., 2015; Marie et al.,
2008), ligament injuries (Abate et al., 2013; Applegate et al.,
2017) and bone stress injuries.30-31. For example, hyper-
cholesterolaemia, diabetes mellitus and the metabolic syndrome
are chronic diseases that are associated with chronic tendinopathy141(Abboud & Kim, 2010; Applegate et al., 2017; Lin et al., 2015).
Prescription medications for chronic diseases such as statins, in-
crease the risk of skeletal muscle myopathy (Mammen, 2016; Marie
et al., 2008), while proton pump inhibitors and corticosteroids may
increase the risk of osteopenia (Daga et al., 2018; Diehl & Johnson,
2016). Finally, there may also be a relationship between chronic
disease and chronic pain in athletes. (Ramanathan et al., 2018).
However, it is important to note that, due to our cross-sectional
design, we cannot establish a cause-effect relationship between
chronic disease and GOIs in cyclists. We do suggest that this rela-
tionship be explored in future research studies. (Ramanathan et al.,
2018) Nevertheless, we recommend that clinicians take note of the
possible association between gradual onset injuries and certain
chronic diseases, particularly when managing patients or intro-
ducing injury prevention programs. This is important, because cy-
clists with a history of chronic disease will benefit greatly from the
Table 5
The adjusted$* frequency (%; with 95%CI) and prevalence ratio (PR; with 95%CI) of cyclists with gradual onset injuries (GOIs) by combined main categories of risk factors
(cycling training/racing history, history of chronic disease and history of medication usage) (multiple regression model).
Cyclists with gradual onset injuries
(GOIs)
% (95% CI)
PR (95% CI) p-value
Cycling training/racing
history


































$*: Adjusted for gender and age group.
a Average increase in risk for 1 more training session per week.
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(American College of Sports et al., 2018).
There is some evidence that increased weekly training and
increased racing frequency is associated with the development of
GOIs in cyclists (Wilber et al., 1995). In one cross-sectional study,
participants were 2.3e4 times more likely to be treated for an
gradual onset injury during the Cycle Across Maryland tour if they
usually cycled less than 26 miles (41.8 km) per week in preparation
for the tour (Dannenberg et al., 1996). We show that increased
average weekly training/racing frequency is a risk factor for GOIs in
recreational cyclists. Others suggested that cyclists with less years
of cycling experience had more buttock and groin complaints
(Weiss, 1985; Wilber et al., 1995), but there was no relationship
between long distance riding experience and any other GOIs in
cyclists (Weiss, 1985).
We show that a history of AAIM medication usage in the week
before or during racing is strongly associated with GOIs in recrea-
tional cyclists. The association between AAIM medication usage
and GOIs in recreational cyclists has not been explored in previous
studies. Again, because of the limitation of our cross-sectional
study design, cause-effect cannot be determined. We speculate
that this finding is likely to be related to the use of AAIM to treat the
symptoms of a GOI before and during cycling races and therefore is
likely to be an effect of the GOI, rather than a cause. However, there
are data to show that anti-inflammatory medication use can also
negatively affect soft tissue and bony healing (Duchesne et al.,
2017; Hainline et al., 2017). This means that regular anti-
inflammatory medication used to treat gradual onset injuries may
also potentially contribute to a failure of the healing response.
Again, this requires further study, but we recommend that clini-
cians take note of the association between AAIM use and gradual
onset injuries when managing cyclists with GOIs. We suggest that
further studies are conducted to determine the prevalence of AAIM
use in cyclists, as well as the risk of medical complications associ-
ated with AAIM during cycling.
We show that gender was not associated with a higher PR of
GOIs in cyclists, but other studies have shown that female cyclists
have an increased risk for developing GOIs, particularly in the neck
(1.5 times), shoulder (2.2 times), and the medial knee (3.1 times)
(Van der Walt et al., 2014; Weiss, 1985; Wilber et al., 1995). How-
ever, in two studies, no significant differences in injury risk at142various anatomical sites was found between male and female cy-
clists (Weiss, 1985; Wilber et al., 1995). The relationship between
gender and risk of GOIs in cyclists requires further study.
Finally, in our study age category >50 years was associated with
a higher prevalence ratio (PR) of GOIs in cyclists, compared to other
age categories, but we did not explore age as a risk factor for GOIs at
specific anatomical sites in cyclists. In two other studies it has been
suggested that younger age is a risk for medial knee pain, back,
buttocks, and upper leg complaints in cyclists (Dannenberg et al.,
1996; Weiss, 1985). In another study, no significant association
between age and cycling injury was found (Van der Walt et al.,
2014). In one prospective observational study where multivariate
analysis was conducted, pain level (at enrolment) and older age
were associated with injuries in cyclists (Dahlquist et al., 2015). To
extrapolate these findings to our study on GOIs in cyclists is not
possible, because of the differences in the definition of injury. In
particular, no distinctionwas made between traumatic injuries and
GOIs in cyclists in this study (Dahlquist et al., 2015).
The main strengths of this study are the large sample size, an
acceptable overall response rate (60%) with a post-hoc analysis that
our study population was, with some limitations, generalizable to
all cycle race entrants. A further significant strength of our study
was that wewere able to conduct multiple regression analyses. This
is also the first study, to our knowledge, that shows underlying
chronic disease, medication usage and a history of a GOIs in cyclists
as intrinsic risk factors associated with GOIs in recreational cycling.
Specific limitations of our study were that our data are self-
reported, with a potential for recall bias. We also acknowledge
that our observations may not be compared to findings in other
studies because of differences in the definition of GOIs. Also, from
our results, we cannot infer cause-effect as this was a cross-
sectional study design. We suggest that further research be aimed
at determining the causal relationship between specific GOIs in
different age groups of cyclists and specific chronic diseases or
medication usage in a larger sample size. We also acknowledge that
we did not explore all possible risk factors, specifically other
intrinsic risk factors related to biomechanical abnormalities and
extrinsic risk factors related to bicycle set-up, that may be associ-
ated with GOIs in cyclists in specific anatomical sites.
F. du Toit, M. Schwellnus, P. Wood et al. Physical Therapy in Sport 46 (2020) 137e1445. Conclusion
Risk factors associated with GOIs in recreational cyclists have
not been well-studied. We identified novel intrinsic risk factors
associated with a history of GOIs in recreational cyclists, using a
multivariate model on a large sample of recreational cyclists
entering for a one-day road cycling event. Average weekly training/
racing frequency in the last 12 months (times per week)], a history
of chronic disease [any symptoms of CVD, any respiratory disease,
and any nervous system/psychiatric disease], and a history of AAIM
usage in the week before or during racing were intrinsic risk factors
associated with GOIs in cyclists. These findings are important for
clinicians who may consider that GOIs in cyclists are not associated
with a single aetiology, but rather a more complex interaction of a
variety of intrinsic and extrinsic factors requiring careful and sys-
tematic clinical assessment. Finally, we acknowledge that future
research is required to determine the cause-effect relationship
between GOIs in cyclists and the factors we identified, and also
explore possible pathophysiological mechanisms that may link
GOIs in cyclists to underlying chronic disease and medication
usage.
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